Skip header and navigation

6 records – page 1 of 1.

[Antithrombin III level in patients with acute viral myocarditis]

https://arctichealth.org/en/permalink/ahliterature53507
Source
Lik Sprava. 2003 Apr-Jun;(3-4):63-5
Publication Type
Article
Author
B H Doroshenko
Source
Lik Sprava. 2003 Apr-Jun;(3-4):63-5
Language
Ukrainian
Publication Type
Article
Keywords
Acute Disease
Adult
Anticoagulants - therapeutic use
Antithrombin III - metabolism
Blood Coagulation - drug effects
Diclofenac - therapeutic use
Drug Therapy, Combination
English Abstract
Heparin - therapeutic use
Humans
Myocarditis - blood - drug therapy - virology
Prednisolone - therapeutic use
Severity of Illness Index
Triazoles - therapeutic use
Virus Diseases - blood - drug therapy
Abstract
The article focuses on the status of a natural anticoagulant antithrombin III in patients with acute viral myocarditis (AVM) and on modes of treatment thereof. It has been proved that there is a statistically significant correlation between a drop in concentration of antithrombin III and degree of severity of AVM. Convincing, statistically significant data have been obtained that antithrombin III gets increased in AVM patients undergoing complex therapy: in those patients running a mild course of the illness, a mild one presenting with elevated indices for homeostasis, a medium gravity course (diclofenac, heparin, thiotriasoline, quick-frozen plasma), and grave course as well (prednizolon, heparin, thiotriasoline, quick-frozen plasma), which fact can be taken account of in choosing a therapeutic regimen.
PubMed ID
12889361 View in PubMed
Less detail

[Fibrinogen concentration status in patients with acute viral myocarditis]

https://arctichealth.org/en/permalink/ahliterature53458
Source
Lik Sprava. 2003 Jul-Aug;(5-6):28-30
Publication Type
Article
Author
B H Doroshenko
Source
Lik Sprava. 2003 Jul-Aug;(5-6):28-30
Language
Ukrainian
Publication Type
Article
Keywords
Acute Disease
Adolescent
Adult
Anti-Inflammatory Agents - therapeutic use
Anti-Inflammatory Agents, Non-Steroidal - therapeutic use
Anticoagulants - therapeutic use
Comparative Study
Diclofenac - therapeutic use
English Abstract
Fibrinogen - analysis
Heparin - therapeutic use
Humans
Male
Middle Aged
Myocarditis - blood - drug therapy - virology
Prednisolone - therapeutic use
Severity of Illness Index
Triazoles - therapeutic use
Virus Diseases - blood - drug therapy
Abstract
The article is devoted to an urgent problem of the status of fibrinogen in patients with acute viral myocarditis and methods of the treatment. It is proved for the first time that a decrease in the concentration of fibrinogen as an indicator of thrombinemia correlates statistically to a great extent with the degree of severity of the condition in patients with acute viral myocarditis. Convincing, statistically significant data have been obtained on a decline in the concentration of fibrinogen in those patients with acute viral myocarditis placed on a complex therapy, running a mild course of the disease, a mild one presenting with elevated indices for hemostasis, and moderately severe course (diclofenac, heparin, thiotriazoline) as well, in grave condition (prednisolone, heparin, thiotriazoline), that can help in choosing of patient treatment tactics.
PubMed ID
14618797 View in PubMed
Less detail

[First and second wave of the aggregation of platelets in patients with acute virus myocarditis and its treatment]

https://arctichealth.org/en/permalink/ahliterature78712
Source
Lik Sprava. 2006 Oct-Nov;(7):22-4
Publication Type
Article
Author
Doroshenko B H
Saliuta M Iu
Nazar P S
Source
Lik Sprava. 2006 Oct-Nov;(7):22-4
Language
Ukrainian
Publication Type
Article
Keywords
Acute Disease
Adolescent
Adult
Drug Therapy, Combination
Humans
Middle Aged
Myocarditis - blood - drug therapy - virology
Platelet Aggregation - drug effects
Platelet Aggregation Inhibitors - administration & dosage - therapeutic use
Severity of Illness Index
Treatment Outcome
Abstract
The author carried out an analysis of first and second wave of the aggregation of platelets in patients with acute virus myocarditis in connection with the stage of clinical course of the disease and therapy done.
PubMed ID
17312881 View in PubMed
Less detail

[The blood coagulation aspects of acute infectious myocarditis]

https://arctichealth.org/en/permalink/ahliterature54375
Source
Lik Sprava. 1998 Mar-Apr;(2):40-3
Publication Type
Article
Author
B H Doroshenko
Source
Lik Sprava. 1998 Mar-Apr;(2):40-3
Language
Ukrainian
Publication Type
Article
Keywords
Acute Disease
Adult
Blood Coagulation - drug effects
Blood Coagulation Tests - methods
Drug Therapy, Combination
English Abstract
Humans
Infection - blood - drug therapy
Myocarditis - blood - drug therapy
Abstract
Overall thirty-four patients with infectious myocarditis were studied by 9 coagulation techniques. A major proportion of this patient population displayed stage I blood disseminated intravascular coagulation syndrome. Treatment with coagulants, antiaggregants or nonsteroid antiinflammatory drugs resulted in positive dynamics of indices for coagulative and thrombovascular hemostasis, which observation significantly correlated with clinical improvement.
PubMed ID
9670651 View in PubMed
Less detail

[The drug correction of functional disorders of blood coagulation and lipid peroxidation in patients with infectious myocarditis]

https://arctichealth.org/en/permalink/ahliterature54257
Source
Lik Sprava. 1998 Dec;(8):3-6
Publication Type
Article
Date
Dec-1998
Author
B H Doroshenko
Source
Lik Sprava. 1998 Dec;(8):3-6
Date
Dec-1998
Language
Ukrainian
Publication Type
Article
Keywords
Blood Coagulation - drug effects
Cardiovascular Agents - therapeutic use
Communicable Diseases - blood - drug therapy - physiopathology
Disseminated Intravascular Coagulation - blood - drug therapy - physiopathology
Drug Therapy, Combination
English Abstract
Hemodynamic Processes - drug effects
Humans
Lipid Peroxidation - drug effects
Myocarditis - blood - drug therapy - physiopathology
Abstract
Carried out in this study for the first time was the diagnosis and treatment per groups of degree of severity of the clinical course of infectious myocarditis. According to the classification of the New York Association of Cardiology (1964, 1973), there has been established a clear correlation between the gravity of the process course, hemodialysis and cardiac haemodynamics.
PubMed ID
10204335 View in PubMed
Less detail

[Use of medications for the correction of functional disturbances in hemocoagulation and lipid peroxidation in patients with infectious myocarditis]

https://arctichealth.org/en/permalink/ahliterature53874
Source
Lik Sprava. 2001 Mar-Apr;(2):140-2
Publication Type
Article
Author
B H Doroshenko
Source
Lik Sprava. 2001 Mar-Apr;(2):140-2
Language
Ukrainian
Publication Type
Article
Keywords
Antioxidants - therapeutic use
Blood Coagulation - drug effects
Diuretics - therapeutic use
Drug Therapy, Combination
English Abstract
Heparin - therapeutic use
Humans
Lipid Peroxidation - drug effects
Myocarditis - blood - drug therapy - virology
Myocardium - metabolism
Prospective Studies
Virus Diseases - blood - drug therapy
Abstract
Disturbances were studied in the system of hemostasis, lipid peroxidation, functional condition of the cardiac muscle in patients with acute mild, moderately severe, and severe viral myocarditis. The studies were made before and after the treatment of patients with basal drug preparations, heparin, antioxidants (thiotriasaline, captopril). Therapeutic benefit from treatment with heparin, thiotriasaline was but insignificant in patients with mild, moderately severe, and severe course of the disease. It was only with the adoption of a complex therapy (basal drug preparations, heparin, thiotriasaline, captopril, diuretics) that patients derived clinical-and-laboratory-instrumental-and-social-and-economic benefit from treatment.
PubMed ID
11519415 View in PubMed
Less detail

6 records – page 1 of 1.